Effects of chronic ET(A)-receptor blockade in angiotensin II-induced hypertension

Hypertension

Volumn 29, Issue 1 II, 1997, Pages 435-441

  D'Uscio, Livius V ^b   Moreau, Pierre ^b   Shaw, Sidney ^b   Takase, Hiroyuki ^b   Barton, Matthias ^b   Lüscher, Thomas F ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b NONE

Author keywords

angiotensin II; aorta; endothelins; endothelium; ET receptors; LU135252

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 7 [3 [(2 HEPTANAMIDOACETAMIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; ACETYLCHOLINE; ANGIOTENSIN; DARUSENTAN; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; NITROPRUSSIDE SODIUM; NORADRENALIN BITARTRATE; UNCLASSIFIED DRUG; ANGIOTENSIN II; DRUG DERIVATIVE; ENDOTHELIN RECEPTOR; THROMBOXANE A2; VASOCONSTRICTOR AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DOSE RESPONSE; HYPERTENSION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SUBCUTANEOUS DRUG ADMINISTRATION; VASCULAR ENDOTHELIUM; VASODILATATION; ANIMAL; BLOOD; BLOOD PRESSURE; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; DRUG EFFECT; MUSCLE RELAXATION; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULAR SMOOTH MUSCLE; WISTAR KYOTO RAT;

ACETYLCHOLINE; ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; HYPERTENSION; MALE; MUSCLE RELAXATION; MUSCLE, SMOOTH, VASCULAR; RATS; RATS, INBRED WKY; RECEPTORS, ENDOTHELIN; THROMBOXANE A2; VASOCONSTRICTOR AGENTS;

EID: 0030636347     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.29.1.435     Document Type: Article

References (48)

1. Lüscher TF, Vanhoutte PM. The Endothelium: Modulator of Cardiovascular Function. Boca Raton, Fla: CRC Press; 1990:1-115.
2. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature, 1980;288:373-376.
3. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987;327:524-526.
4. Moncada S, Vane JR. Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2 and prostacyclin. Pharmacol Rev. 1978;30:293-331.
5. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988; 332:411-415.
6. Inoue A, Yanagisawa M, Kimura S, Kasuya Y, Miyauchi T, Goto K, Masaki T. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci U S A. 1989;86:2863-2867.
7. Lüscher TF, Boulanger CM, Dohi Y, Yang Z. Endothelium-derived contracting factors. Hypertension. 1992;19:117-130.
8. Hirata Y, Takagi Y, Fukuda Y, Marumo F. Endothelin is a potent mitogen for rat vascular smooth muscle cells. Atherosclerosis. 1989; 78:225-228.
9. Yanagisawa M, Masaki T. Molecular biology and biochemistry of the endothelins. Trends Pharmacol Sci. 1989;10:374-378
10. Boulanger C, Lüscher TF. Release of endothelin from the porcine aorta: inhibition by endothelium-derived nitric oxide. J Clin Invest. 1990;85:587-590.
11. Seo B, Lüscher TF. ETA and ETB receptors mediate contractions to endothelin-1 in renal artery of aging SHR: effects of FR139317 and bosentan. Hypertension. 1995;25:501-506.
12. Sakurai T, Yanagisawa M, Takuwa Y, Miyazaki H, Kimura S, Goto K, Masaki T. Cloning of acDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature. 1990;348:732-735.
13. Vane J. Endothelins come home to roost. Nature. 1990;348:673.
14. Li JS, Schiffrin EL. Effect of chronic treatment of adult spontaneously hypertensive rats with an endothelin receptor antagonist. Hypertension. 1995;25:495-500.
15. Schricker K, Scholz H, Hamann M, Clozel M, Kramer BK, Kurtz A, Role of endogenous endothelins in the renin system of normal and two-kidney, one clip rats. Hypertension. 1995;25:1025-1029.
16. Douglas SA, Gellai M, Ezekiel M, Ohlstein EH. BQ-123, a selective endothelin subtype A-receptor antagonist, lowers blood pressure in different rat models of hypertension. J Hypertens. 1994;12:561-567.
17. Lee MA, Böhm M, Paul M, Ganten D. Tissue renin-angiotensin systems: their role in cardiovascular disease. Circulation. 1993;87(suppl IV):IV-7-IV-13.
18. Dzau VJ. Local expression and pathophysiological role of renin-angiotensin in the blood vessels and heart. In: Grobecker H, Heusch G, Strauer BE, eds. Angiotensin and the Heart. Darmstadt, Germany: Steinkopff Verlag; 1993:1-14.
19. Seyedi N, Xu X, Nasjletti A, Hintze TH. Coronary kinin generation mediates nitric oxide release after angiotensin receptor stimulation. Hypertension. 1995;26:164-170.
20. 1-mediated release of nitric oxide decreases angiotensin II contractions in rat carotid artery. Hypertension. 1995;26:752-757.
21. Wilcox CS, Welch WJ. Thromboxane mediation of the pressor response to infused angiotensin II. Am J Hypertens. 1990;3:242-249.
22. Sung CP, Arleth AJ, Storer BL, Ohlstein EH. Angiotensin type 1 receptors mediate smooth muscle proliferation and endothelin biosynthesis in rat vascular smooth muscle. J Pharmacol Exp Ther. 1994;271:429-437.
23. Dubey RK, Jackson EK, Lüscher TF. Nitric oxide inhibits angiotensin II-induced migration of rat aortic smooth muscle cell: role of cyclic-nucleotides and angiotensin 1 receptors. J Clin Invest. 1995; 96:141-149.
24. Emori T, Hirata Y, Ohta K, Kanno K, Eguchi S, Imai T, Shichiri M, Marumo F. Cellular mechanism of endothelin-1 release by angiotensin and vasopressin. Hypertension. 1991;18:165-170.
25. Imai T, Hirata Y, Emori T, Yanagisawa M, Masaki T, Marumo F, Induction of endothelin-1 gene by angiotensin and vasopressin in endothelial cells. Hypertension. 1992;19:753-757.
26. Paul M, Zintz M, Böcker W, Dyer M. Characterization and functional analysis of the rat endothelin-1 promoter. Hypertension. 1995;25: 683-687.
27. Dohi Y, Hahn A, Boulanger CM, Bühler FR, Lüscher TF. Endothelin stimulated by angiotensin II augments contractility of spontaneously hypertensive rat resistance arteries. Hypertension. 1992;19:131-137.
28. Yang Z, Richard V, Segesser L, Bauer E, Stulz P, Turina M, Lüscher TF. Threshold concentrations of endothelin-1 potentiate contractions to norepinephrine and serotonin in human arteries: a new mechanism of vasospasm? Circulation. 1990;82:188-195.
29. Münter K, Hergenröder S, Unger L, Kirchengast M. Oral treatment with an ETA-receptor antagonist inhibits neointima formation induced by endothelial injury. Pharm Pharmacol Lett. 1996;16:90-92.
30. Raschack M, Unger L, Riechers H, Klinge D. Receptor selectivity of endothelin antagonists and prevention of vasoconstriction and endothelin-induced sudden death. J Cardiovasc-Pharmacol. 1995;26 (suppl 3):S397-S399.
31. Auch-Schwelk W, Katusic ZS, Vanhoutte PM. Thromboxane A2 receptor antagonists inhibit endothelium-dependent contractions. Hypertension. 1990;15:699-703.
32. Auch-Schwelk W, Katusic ZS, Vanhoutte PM. Contractions to oxygen-derived free radicals are augmented in aorta of the spontaneously hypertensive rats. Hypertension. 1989;13:859-864.
33. Rees DD, Palmer RMJ, Hodson HF, Moncada S. A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation. Br J Pharmacol. 1989;96:418-424.
34. Sœrensen S. Radioimmunoassay of endothelin in human plasma. Scand J Clin Lab Invest. 1991;51:615-623.
35. Riechers H, Albrecht, H-P, Amberg W, Baumann E, Bernard H, Böhm H-J, Klinge D, Kling A, Müller S, Raschack M, Unger L, Walker N, Wernet W. Discovery and optimization of a novel class of orally active nonpeptidic endothelin-A receptor antagonists. J Med Chem. 1996;39:2123-2128.
36. Wallenstein S, Zucker CL, Fleiss J. Some statistical methods useful in circulation research. Circ Res. 1980;47:1-9.
37. Rajagopalan S, Kurz S, Münzel T, Tarpey M, Freeman BA, Griendling KK, Harrison DG. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: contribution to alternations of vasomotor tone J Clin Invest. 1996;97:1916-1923.
38. Brink M, Wellen J, Delafontaine P. Angiotensin II causes weight loss and decreases circulating insulin-like growth factor I in rats through a pressor-independent mechanism. J Clin Invest. 1996;97:2509-2516.
39. Hahn AWA, Resink TJ, Scott-Burden T, Powell J, Dohi Y, Bühler FR. Stimulation of endothelin mRNA and secretion in rat vascular smooth muscle cells: a novel autocrine function. Cell Regul. 1990; 1:649-659.
40. Ito H, Hirata Y, Adachi S, Tanaka M, Tsujmo M, Koike A, Nogami A, Marumo F, Hiroe M. Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes. J Clin Invest. 1993;92:398-403.
41. Chen L, McNeill RJ, Wislon TW, Gopalakrishnan V. Heterogeneity in vascular smooth muscle responsiveness to angiotensin II: role of endothelin. Hypertension. 1995;26:83-88.
42. Wagner OF, Christ G, Wojta J, Vierhapper H, Parzer S, Nowotny PJ, Schneider B, Waldhausl W, Binder BR. Polar secretion of endothelin-1 by cultured endothelial cells. J Biol Chem. 1992;267:16066-16068.
43. Goldberg MR, Tanaka W, Barchowsky A, Bradstreet TE, McCrea J, Lo M-W, McWilliams EJ Jr, Bjomsson TD. Effects of losartan on blood pressure, plasma renin activity, and angiotensin II in volunteers Hypertension. 1993;21:704-713.
44. A-receptor blockade on blood pressure and endothelial function in chronic nitric oxide deficiency. Hypertension. 1996;28:695. Abstract.
45. Moreau P, Takase H, Küng CF, Shaw S, Lüscher TF. Chronic endothelin receptor blockade in nitric oxide deficient hypertension. Hypertension. In press.
46. Rapoport RM, Draznin MB, Murad F. Endothelium-dependent relaxation in rat aorta may be mediated through cyclic GMP-dependent protein phosphorylation. Nature. 1983;306:174-176.
47. Moreau P, Takase H, Lüscher TF. Effect of endothelin antagonists on the responses to prostanoid endothelium-derived contracting factors. Br J Pharmacol. 1996;118:1429-1432.
48. Küng CF, Lüscher TF. Different mechanisms of endothelial dysfunction with aging and hypertension in rat aorta. Hypertension. 1995;25:194-200.